Clinical Trial Update: Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of ranolazine to glimepiride in subjects with type 2 diabetes mellitus; the study has completed and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Ranolazine (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-09-01